LLY

806.87

-1.43%↓

JNJ

155.12

-1.13%↓

ABBV

190.75

+0.09%↑

NVO

76.95

-3.5%↓

UNH

307.68

-1.78%↓

LLY

806.87

-1.43%↓

JNJ

155.12

-1.13%↓

ABBV

190.75

+0.09%↑

NVO

76.95

-3.5%↓

UNH

307.68

-1.78%↓

LLY

806.87

-1.43%↓

JNJ

155.12

-1.13%↓

ABBV

190.75

+0.09%↑

NVO

76.95

-3.5%↓

UNH

307.68

-1.78%↓

LLY

806.87

-1.43%↓

JNJ

155.12

-1.13%↓

ABBV

190.75

+0.09%↑

NVO

76.95

-3.5%↓

UNH

307.68

-1.78%↓

LLY

806.87

-1.43%↓

JNJ

155.12

-1.13%↓

ABBV

190.75

+0.09%↑

NVO

76.95

-3.5%↓

UNH

307.68

-1.78%↓

Search

10X Genomics Inc (Class A)

Gesloten

SectorGezondheidszorg

11.04 6.26

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

10.17

Max

11.17

Belangrijke statistieken

By Trading Economics

Inkomsten

15M

-34M

Verkoop

-10M

155M

EPS

-0.102

Winstmarge

-22.183

Werknemers

1,306

EBITDA

-1.5M

-39M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+24.76% upside

Dividenden

By Dow Jones

Volgende Winsten

7 aug 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

100M

1.2B

Vorige openingsprijs

4.78

Vorige sluitingsprijs

11.04

Nieuwssentiment

By Acuity

34%

66%

99 / 381 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Bullish Evidence

10X Genomics Inc (Class A) Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

16 jun 2025, 22:33 UTC

Acquisities, Fusies, Overnames

KKR to Acquire Australian Power Provider Zenith Energy

16 jun 2025, 21:55 UTC

Belangrijke Marktbewegers

Geospace Technologies Shares Up on Petrobras Pact

16 jun 2025, 17:04 UTC

Belangrijke Marktbewegers

Roku Shares Climb on Advertising Deal with Amazon

16 jun 2025, 23:51 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

16 jun 2025, 23:51 UTC

Marktinformatie

Nikkei May Trade Range Bound Amid Israel-Iran Conflict -- Market Talk

16 jun 2025, 23:41 UTC

Marktinformatie

Gold Edges Higher Amid Ongoing Geopolitical Tensions -- Market Talk

16 jun 2025, 23:10 UTC

Marktinformatie
Acquisities, Fusies, Overnames

XRG Has 'Viable Path' to Approval of Santos Takeover -- Market Talk

16 jun 2025, 23:02 UTC

Marktinformatie

Auckland Airport Unlikely to Hit Target for International Passengers -- Market Talk

16 jun 2025, 22:32 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Santos Unlikely to Attract Rival Bidder to XRG -- Market Talk

16 jun 2025, 22:03 UTC

Acquisities, Fusies, Overnames

KKR & Co. to Buy Zenith Energy From Consortium Including Pacific Equity Partners, OPSEU Pension Trust, Foresight Group >KKR

16 jun 2025, 22:00 UTC

Acquisities, Fusies, Overnames

KKR Acquires Leading Australian Independent Power Producer Zenith Energy >KKR

16 jun 2025, 21:56 UTC

Winsten

Lennar Has an Earnings Miss. The Stock Slips. -- Barrons.com

16 jun 2025, 21:10 UTC

Acquisities, Fusies, Overnames

Mitsubishi in Talks to Sign $8 Billion Deal With Gas Producer Aethon -- WSJ

16 jun 2025, 20:50 UTC

Marktinformatie

Financial Services Roundup: Market Talk

16 jun 2025, 20:50 UTC

Marktinformatie

Tech, Media & Telecom Roundup: Market Talk

16 jun 2025, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

16 jun 2025, 20:49 UTC

Marktinformatie

Fitch Revises Canadian Provinces Fiscal Outlook to 'Deteriorating' -- Market Talk

16 jun 2025, 20:14 UTC

Acquisities, Fusies, Overnames

Update: EchoStar Stock Surges. It's Short Covering and President Trump. -- Barrons.com

16 jun 2025, 20:13 UTC

Marktinformatie

Natural Gas Gains on Warmer Outlook -- Market Talk

16 jun 2025, 19:58 UTC

Acquisities, Fusies, Overnames

OpenAI and Microsoft Tensions Are Reaching a Boiling Point -- WSJ

16 jun 2025, 19:13 UTC

Marktinformatie

Middle-East Conflict May Not Push Up Oil Long Term -- Market Talk

16 jun 2025, 19:09 UTC

Marktinformatie

Amazon-Roku Deal Shows Competition for Streaming Ad Space -- Market Talk

16 jun 2025, 18:43 UTC

Marktinformatie

May Could Mark Nascent Recovery in Canada Housing Market -- Market Talk

16 jun 2025, 18:36 UTC

Marktinformatie

Soybeans May Get Boost from Renewable Fuel Obligations -- Market Talk

16 jun 2025, 18:29 UTC

Marktinformatie

Global Equities Roundup: Market Talk

16 jun 2025, 18:29 UTC

Marktinformatie

Shopify Appears More Resilient Than Feared -- Market Talk

16 jun 2025, 18:22 UTC

Marktinformatie

Citi Forecasts Downturn in Gold Futures -- Market Talk

16 jun 2025, 16:42 UTC

Marktinformatie

Homebuyers' Downpayments Are Shrinking For First Time in 2 Years -- Market Talk

16 jun 2025, 16:37 UTC

Marktinformatie

Big, Beautiful Bill Might Not Mean Big Growth -- Market Talk

16 jun 2025, 16:20 UTC

Marktinformatie

Financial Services Roundup: Market Talk

Peer Vergelijking

Prijswijziging

10X Genomics Inc (Class A) Prognose

Koersdoel

By TipRanks

24.76% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 13 USD  24.76%

Hoogste 18 USD

Laagste 9 USD

Gebaseerd op 10 Wall Street-analisten die 12-maands prijsdoelen bieden voor 10X Genomics Inc (Class A) - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

10 ratings

4

Buy

6

Hold

0

Sell

Technische score

By Trading Central

8.32 / 8.63Steun & Weerstand

Korte Termijn

Bullish Evidence

Gemiddeld Termijn

Bullish Evidence

Lange Termijn

No Evidence

Sentiment

By Acuity

99 / 381 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over 10X Genomics Inc (Class A)

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.